Provided by Tiger Fintech (Singapore) Pte. Ltd.

KINTOR PHARMA-B

1.460
+0.1208.96%
Volume:5.68M
Turnover:8.35M
Market Cap:653.35M
PE:-3.71
High:1.520
Open:1.300
Low:1.300
Close:1.340
Loading ...

Company Profile

Company Name:
KINTOR PHARMA-B
Exchange:
SEHK
Establishment Date:
2009
Employees:
168
Office Location:
Suzhou Industrial Park,No.20 Songbei Road,China (Jiangsu) Pilot Free Trade,Suzhou,Jiangsu Province,China
Zip Code:
215123
Fax:
- -
Introduction:
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China. The Company is focused on the research and development of drugs for cancers and other androgen receptor (AR) related diseases. Its primary drug candidate is Proxalutamide which is in phase III clinical trials in China for metastatic castration-resistant prostate cancer (mCRPC). The Company are also developing other drug candidates, including a phase II small molecule drug candidate Pyrilutamide, a phase II monoclonal antibody drug candidate ALK-1, a phase I mTOR inhibitor drug candidate Detorsertib and an inhibitor of the hedgehog signal translation pathway GT1708F.

Directors

Name
Position
TONG You Zhi
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
NI Xiang
Executive Director
XU Min
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
YANG Huai Yan
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
TONG Liang
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Member
GAO Wei Peng
Director
WEI Ge Qi
Director

Shareholders

Name
Position
TONG You Zhi
CEO
MA Lian Dong
Vice General Manager,Other Senior Executives
XU Re
Vice General Manager
YANG Jian Fei
Vice General Manager
CHEN Ju Ping
Vice General Manager
CHEN Jie
Vice General Manager
ZHANG Ming Ming
CFO,Corporate Secretary
LU Qun
CTO
HUANG Wei Chao
Corporate Secretary
HAN Jia Wen
Other Senior Executives
NI Xiang
Other Senior Executives